Ocuphire Pharma Inc. Stock
Your prediction
Ocuphire Pharma Inc. Stock
The Ocuphire Pharma Inc. stock is trending slightly upwards today, with an increase of €0.020 (0.960%) compared to yesterday's price.
Our community identified positive and negative aspects for Ocuphire Pharma Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Ocuphire Pharma Inc. stock. On the other hand our users think that "Innovation" could be a problem in the future.
Pros and Cons of Ocuphire Pharma Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ocuphire Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ocuphire Pharma Inc. | 0.960% | 2.145% | 17.647% | 85.874% | 80.180% | -31.973% | - |
| NanoViricides Inc. | -0.910% | 4.808% | -13.492% | -21.014% | -27.333% | -19.319% | -61.888% |
| Actinium Pharmaceuticals Inc. | 0.810% | 4.739% | 14.159% | 1.989% | 11.381% | -87.218% | -86.505% |
| Immunic Inc. | -2.150% | -7.986% | -19.207% | -51.152% | -47.577% | -55.518% | -96.467% |
Comments
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its price target lowered by analysts at HC Wainwright from $20.00 to $18.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its price target lowered by analysts at Alliance Global Partners from $24.00 to $20.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OCUP provided by MarketBeat
